Thiogalactosides

"Thiogalactosides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Galactosides in which the oxygen atom linking the sugar and aglycone is replaced by a sulfur atom.

Descriptor ID

D013862

MeSH Number(s)

D02.886.740.600

D09.408.320.820

D09.408.903.600

Concept/Terms

Thiogalactosides

Below are MeSH descriptors whose meaning is more general than "Thiogalactosides".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Sulfur Compounds [D02.886]
Thioglycosides [D02.886.740]
Thiogalactosides [D02.886.740.600]
Carbohydrates [D09]
Glycosides [D09.408]
Galactosides [D09.408.320]
Thiogalactosides [D09.408.320.820]
Thioglycosides [D09.408.903]
Thiogalactosides [D09.408.903.600]

Below are MeSH descriptors whose meaning is related to "Thiogalactosides".

Below are MeSH descriptors whose meaning is more specific than "Thiogalactosides".

Thiogalactosides
Isopropyl Thiogalactoside

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Thiogalactosides" by people in Harvard Catalyst Profiles by year, and whether "Thiogalactosides" was a major or minor topic of these publication.

Bar chart showing 3 publications over 3 distinct years, with a maximum of 1 publications in 2009 and 2011 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2009	0	1	1
2011	1	0	1
2022	0	1	1

Below are the most recent publications written about "Thiogalactosides" by people in Profiles.

Genetic targeting or pharmacological inhibition of galectin-3 dampens microglia reactivity and delays retinal degeneration. J Neuroinflammation. 2022 Sep 17; 19(1):229.

View in: PubMed
A novel carbon monoxide-releasing molecule fully protects mice from severe malaria. Antimicrob Agents Chemother. 2012 Mar; 56(3):1281-90.

View in: PubMed
Activation of human invariant natural killer T cells with a thioglycoside analogue of a-galactosylceramide. Clin Immunol. 2011 Aug; 140(2):196-207.

View in: PubMed
Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer. Mol Cancer Res. 2009 Oct; 7(10):1655-62.

View in: PubMed
Sugar recognition mutants of the melibiose carrier of Escherichia coli: possible structural information concerning the arrangement of membrane-bound helices and sugar/cation recognition site. Biochim Biophys Acta. 2000 Dec 20; 1509(1-2):123-30.

View in: PubMed
Alteration of Na(+)-coupled transport in site-directed mutants of the melibiose carrier of Escherichia coli. Biochim Biophys Acta. 1996 Jul 25; 1282(2):240-8.

View in: PubMed
Characterization and sequencing of an uncoupled lactose carrier mutant of Escherichia coli. Biochem Biophys Res Commun. 1994 Apr 15; 200(1):268-74.

View in: PubMed
Amino acid substitution in the lactose carrier protein with the use of amber suppressors. J Bacteriol. 1992 Aug; 174(16):5436-41.

View in: PubMed
The interaction between aspartic acid 237 and lysine 358 in the lactose carrier of Escherichia coli. Biochim Biophys Acta. 1991 Feb 25; 1062(2):177-86.

View in: PubMed
Galactoside-dependent proton transport by mutants of the Escherichia coli lactose carrier: substitution of tyrosine for histidine-322 and of leucine for serine-306. Biochim Biophys Acta. 1989 Jul 10; 982(2):253-64.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

Clin Immunol
Biochim Biophys Acta
Antimicrob Agents Chemother
J Bacteriol
Mol Cancer Res
Membr Biochem
J Neuroinflammation
J Mol Biol
Biochem Biophys Res Commun